Avantel dispatches postal ballot notice to shareholders for MOA alteration
- Avantel dispatched physical letters to shareholders with unregistered emails regarding the Postal Ballot
- Remote e-voting runs from September 23 to October 22, 2026, for MOA alteration approval
- Merger of wholly owned subsidiary Imeds Global involves no cash consideration or new share allotment
- New business objects include medical devices, space technology, AI, and semiconductor packaging

*this image is generated using AI for illustrative purposes only.
Avantel Limited has dispatched physical communication letters to shareholders whose email addresses are not registered, informing them of the Postal Ballot process. This step ensures all members can access the Notice of Postal Ballot dated September 18, 2026, seeking approval to alter the Objects Clause of its Memorandum of Association.
The dispatch complies with Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication provides a web link to the Company's website where the full notice can be accessed. Remote e-voting commenced at 9:00 am on Wednesday, September 23, 2026, and will conclude at 5:00 pm on Thursday, October 22, 2026. Results are scheduled for declaration on Friday, October 23, 2026.
Context of MOA Alteration
The proposed alteration is directly linked to the company's strategic pivot and the approved merger of its wholly owned subsidiary, Imeds Global Private Limited. The new objects clause (Clauses 16 to 21) broadens Avantel's mandate to include:
- Medical devices, healthcare technology, telemedicine, and life sciences research.
- Satellite systems, space technology, ground station services, and remote sensing.
- Energy systems including nuclear, solar, wind, hydrogen, and battery storage.
- Mechanical, electrical, and electronic manufacturing services.
- Microelectronics, semiconductor packaging, and testing facilities.
- Artificial intelligence, machine learning, cybersecurity, and data centres.
Merger Details and Financials
The decisions were taken during a board meeting held on September 18, 2026, at the company’s corporate office in Hyderabad. The meeting commenced at 10:30 am and concluded at 3:10 pm.
The scheme of merger involves the consolidation of Imeds Global (Transferor Company) into Avantel Limited (Transferee Company). This transaction is governed by Sections 230 to 232 of the Companies Act, 2013.
Since Imeds Global is a wholly owned subsidiary, no cash consideration is proposed, and no shares of Avantel will be allotted. The equity shares held by Avantel in Imeds Global will be extinguished upon the scheme becoming effective. Consequently, there will be no change in Avantel’s shareholding pattern.
| Entity | Revenue (FY26) | Net Worth (as on March 31, 2026) |
|---|---|---|
| Imeds Global Private Limited | ₹160.32 lakh | ₹2,182.83 lakh |
| Avantel Limited | ₹22,135.23 lakh | ₹35,650.45 lakh |
Figures in ₹ lakh
Rationale and Regulatory Compliance
The company stated that the merger aims to rationalise the group structure, simplify governance and reporting, and eliminate duplication of administrative functions. The transaction falls under the exemption provided under Regulation 23(5)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as it involves a wholly owned subsidiary.
The expanded scope requires shareholder approval via postal ballot. In compliance with MCA General Circulars, the notice has been sent electronically to members whose email addresses are registered as on the cut-off date of September 18, 2026. KFin Technologies Limited has been engaged to facilitate the remote e-voting process.
Voting Eligibility and Contact Details
Members whose names appear in the Register of Members or Register of Beneficial Owners as on the cut-off date of September 18, 2026, are entitled to cast their votes through the remote e-voting facility only. Shareholders holding shares in physical form who have not updated their KYC details may submit Form ISR-1 along with prescribed documents to the Registrar and Share Transfer Agent to register their email address.
For shares held in Demat form, investors should contact their respective Depository Participants. For physical holdings, requests should be directed to KFin Technologies Limited, the company's Registrar and Share Transfer Agent.
Trading Window Closure
In compliance with insider trading norms, the trading window for dealing in Avantel securities was closed from September 13, 2026. It remains closed until 48 hours after the declaration of the board meeting outcome.
Historical Stock Returns for Avantel
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.19% | -6.39% | -0.51% | -8.64% | -20.65% | -25.72% |
How will Avantel plan to fund the capital-intensive expansion into semiconductor manufacturing and space technology given its current net worth?
What specific strategic partnerships or joint ventures is Avantel pursuing to operationalize its new mandate in AI and cybersecurity?
How does the integration of Imeds Global's healthcare assets align with Avantel's existing telecom infrastructure to create synergies in telemedicine?


































